Directly or indirectly, cancer will touch everyone's lives. There is no greater or more worthwhile challenge than the ongoing battle to develop and improve anti-cancer treatments, for everyone's sake.
 |
programme of research
University of York
2001/2
YCR Cancer Research Unit
Director: Professor N.J. Maitland
N.J. Maitland
R.M. Sharrard
J.Hall
Gene therapy for prostate cancer
J.E. Burns
N.J. Maitland
Structure and functional studies of human papillomavirus E2 proteins
J.E. Burns
N.J. Maitland
Expression, purification and functional studies using HPV2A E1 protein
R.M. Sharrard
N.J. Maitland
Regulation of protein kinase B/AKT in human prostatic cell lines
S.H. Lang
N.J. Maitland
Three dimensional in vitro modelling of the prostate
I.B. Bronstein
Structural and functional analysis of Mts1 and related S100 proteins
YCR P53 Research Laboratory
Director: Professor J Milner
C. Rubbi
J. Milner
Cell biology of the tumour suppressor p53
A. Okorokov
L. Warnock
J. Milner
Molecular biology of the tumour suppressor p53
M. Jiang
J. Milner
Activation of p53 following exposure to DNA damage
F. Chan
C.Rubbi
J. Milner
Transactivation-independent functions of p53
S. Allison
J. Milner
Selective inhibition of oncogenic functions of mutant p53
J. Ford
J. Milner
p53 acetylation
Department of Chemistry
Head of Department: Professor R.N. Perutz
R.J.K. Taylor
Preussomerins, Deoxypreussomerins and Diepoxins:Natural productleads for the synthesis of novel anti-tumour agents
R.J.K. Taylor
Novel anti-tumour agents from marine natural products
|